|
2501
|
|
|
DAB adaptor protein 2 |
DOC-2, DOC2 |
|
|
2502
|
|
|
Chromosome 11 open reading frame 65 |
MFI |
Adrenocortical adenoma, Ataxia telangiectasia, Ataxia-telangiectasia syndrome, Breast cancer, Breast carcinoma, Carcinoma, Cerebellar ataxia, Colorectal cancer, Ductal carcinoma, Glioblastoma, Glioma, Hereditary breast and ovarian cancer syndrome, Hereditary cancer syndrome, Immunologic deficiency syndromes, Islet cell tumor, Lipoma, Lymphoid leukemia, Malignant lymphoma, lymphocytic, intermediate differentiation, Malignant melanoma of skin, Mammary neoplasms, Melanoma, Movement disorders, Nonmedullary thyroid carcinoma, Osteoma, Ovarian neoplasm, Paraganglioma, Plexiform leiomyoma, Sarcoma, T-cell prolymphocytic leukemia, Uterine fibroidsView all (15 more) |
|
2503
|
|
|
Dachshund family transcription factor 1 |
DACH |
|
|
2504
|
|
|
Transmembrane O-mannosyltransferase targeting cadherins 2 |
IBDBP1 |
|
|
2505
|
|
|
C-type lectin domain family 12 member A |
CD371, CLL-1, CLL1, DCAL-2, MICL, hKLRL1 |
|
|
2506
|
|
|
C-type lectin like 1 |
CLECL1P, DCAL-1, DCAL1 |
|
|
2507
|
|
|
CD55 molecule (Cromer blood group) |
CHAPLE, CR, CROM, DAF, TC |
Budd-chiari syndrome, Complement component deficiency, Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome, Endometrioma, Endometriosis, Hepatic vein thrombosis, Hypoalbuminemia, Hypogammaglobulinemia, Hypoproteinemia, Idiopathic hypercatabolic hypoproteinemia, Intestinal lymphatic obstruction, Intestinal obstruction, Iron deficiency anemia, Malabsorption syndrome, Protein-losing enteropathy |
|
2508
|
|
|
Transmembrane O-mannosyltransferase targeting cadherins 3 |
LIS8, SMILE |
Agyria, Aortic aneurysm, Aortic valve insufficiency, Cobblestone lissencephaly, Developmental delay, Gastroesophageal reflux disease, Hypoplasia of corpus callosum, Lissencephaly, Mental retardation, Optic atrophy, Pachygyria, Patent ductus arteriosus, Periventricular nodular heterotopia, Polymicrogyria, Scoliosis |
|
2509
|
|
|
Lamin tail domain containing 1 |
IFLTD1, LMNARS1, PAS1C1 |
|
|
2510
|
|
|
Dystroglycan 1 |
156DAG, A3a, AGRNR, DAG, LGMDR16, MDDGA9, MDDGC7, MDDGC9 |
Absence of septum pellucidum, Agenesis of corpus callosum, Agyria, Alpha-dystroglycanopathy, Ankylosing spondylitis, Arthritis, Autoimmune diseases, Autoimmune thyroiditis, Cataract, Celiac disease, Cerebellar hypoplasia, Common variable immunodeficiency, Congenital coloboma of iris, Congenital hypoplasia of penis, Congenital muscular dystrophy, Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, Crohn disease, Cryptorchidism, Dandy-walker syndrome, Developmental delay, Diabetes mellitus, Fukuyama type congenital muscular dystrophy, Glaucoma, Glaucoma, congenital, Hydrocephalus, Hypoplasia of corpus callosum, Mental retardation, Leukodystrophy, Limb-girdle muscular dystrophy, Limb-girdle muscular dystrophy-dystroglycanopathy, Lupus erythematosus, Macrocephaly, Mental depression, Microcephaly, Microcornea, Microphthalmos, Mood disorder, Motor delay, Muscle eye brain disease, Muscle-eye-brain disease with bilateral multicystic leucodystrophy, Muscular dystrophy, Muscular dystrophy-dystroglycanopathy, Myopia, Optic atrophy, Pachygyria, Polymicrogyria, Posteriorly rotated ear, Prostatic neoplasms, Prostate cancer, Psoriasis, Respiratory failure, Retinal detachment, Retinal dysplasia, Retinal dystrophy, Specific learning disorder, Submucosal cleft palate, Syndromic microphthalmia, Ulcerative colitis, Walker-warburg congenital muscular dystrophy, Walker-warburg syndromeView all (45 more) |
